Zealand and Roche are jointly developing the drug petrelintide which in a mid-stage study led to a worse-than-expected 10.7% ...
The U.S. says it has hit more than 3,000 Iranian targets in the first week of the war, as Iran's president vows to halt attacks on neighbors.
'Mad Money' host Jim Cramer talks what caused the Dow's worst week since April 2025.
Mad Money' host Jim Cramer looks at semiconductor stock Marvell technologies and its recent pop after earnings.
Mad Money' host Jim Cramer weighs in on viewer stock questions. Got a confidential news tip? We want to hear from you. Sign ...
'Mad Money' host Jim Cramer digs in to Formula 1 stocks after a recent pullback.
'Mad Money' host Jim Cramer answers questions from viewers on their top concerns in a volatile market.
Mad Money' host Jim Cramer looks ahead to next weeks market moving moments. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your ...
Mad Money' host Jim Cramer looks ahead to next weeks market moving moments. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your ...
Palantir's stock had its best week since August and outperformed all of its large-cap tech peers after the U.S. attacked Iran ...
Amazon joined Microsoft and Google in continue to offer Anthropic's Claude AI technology to customers after the Pentagon ...
Anthropic CEO says 'no choice' but to challenge Trump admin's supply chain risk designation in court
Anthropic said even with the designation, the government can't forbid it from working with companies in other capacities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results